Differential metabolism and pharmacokinetics of L-[1-11C]-methionine and 2-[18F] fluoro-2-deoxy-D-glucose (FDG) in androgen independent prostate cancer

Clinical Positron Imaging (Netherlands)

Volumn 2, Issue 3, 1999, Pages 173-181

  Macapinlac, Homer A ^a,d   Humm, John L ^b   Akhurst, Timothy ^a   Osman, Iman ^c   Pentlow, Keith ^b   Shangde, Cai ^d   Yeung, Henry W D ^a   Squire, Olivia ^a   Finn, Ronald D ^d   Scher, Howard I ^c   Larson, Steven M ^a  

^a Nuclear Medicine Service   (United States)

^b Department of Medical Physics ^*  (United States)

^c Genitourinary Oncology Service   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

C 11 Methionine; FDG; PET; Prostate Cancer

Indexed keywords

EID: 0008039230     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(99)00015-1     Document Type: Article

References (21)

1. S.M. Larson Positron emission tomography in oncology and allied diseases V.T. DeVita S. Hellman S.A. Rosenberg Cancer Principles and practice of oncology 1989 J.B. Lippincott Philadelphia
2. S. Yeh M. Imbriaco S. Larson Detection of bony metastases of androgen independent prostate cancer by PET-FDG Nuclear Med. Biol. 23 1996 693 697
3. P.D. Shreve H.B. Grossman M.D. Gross R.L. Wahl Metastatic prostate cancer initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose Radiology 199 1996 751 756
4. S. Nilsson K. Kalkner C. Ginman C-11 methionine positron emission tomography in the management of prostatic carcinoma Antibody Immunoconj. Radiopharm. 8 1995 23
5. 11C]methionine Appl. Radiat. Isot. 39 1988 311 314
6. T.R. DeGrado T.G. Turkington J.J. Williams C.W. Stearns J.M. Hoffman R.E. Coleman Performance characteristics of a whole-body PET scanner J. Nucl. Med. 35 1994 1398 1406
7. 11C]methionine in human plasma Eur. J. Nucl. Med. 15 1989 665 669
8. Y.E. Erdi O. Mawlawi S.M. Larson Lung lesion volume estimates by adaptive PET image thresholding Cancer 80 1997 2505 2509
9. G.S. Gerber R. Goldberg G.W. Chodak Local staging of prostate cancer by tumor volume, prostate-specific antigen, and transrectal ultrasound Urology 40 1992 311 316
10. M.L. Schiebler M.D. Schnall H.M. Pollack Current role of MR imaging in the staging of adenocarcinoma of the prostate Radiology 189 1993 339 352
11. G. Weber Enzymology of cancer cells N. Engl. J. Med. 296 1977 541 551
12. O. Warburg The metabolism of tumors 1931 Richard R. Smith New York
13. F. Kallinowski K.H. Schlenger S. Runkel Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts Cancer Res. 49 1989 3759 3764
14. J.S. Flier M.M. Mueckler P. Usher H.F. Lodish Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes Science 235 1987 1495 1498
15. M. Younes L.V. Lechago J.R. Somoano M. Mosharaf J. Lechago Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers Cancer Res. 56 1996 1164 7116
16. G. Fischer I. Ruschenburg E. Eigenbrodt N. Katz Decrease in glucokinase and glucose-6-phosphatase and increase in hexokinase in putative preneoplastic lesions of the rat liver J. Cancer Res. Clin. Oncol. 113 1987 430 436
17. R.L. Wahl PET in oncology in nuclear medicine in tumor diagnosis and therapy I.P.C. Murray P.J. Ell Nuclear medicine in clinical diagnosis and treatment 1995 Churchill Livingstone New York
18. S. Leskinen K. Pulkki J. Knuuti Transport of carbon-11-methionine is enhanced by insulin J. Nucl. Med. 38 1997 1967 1970
19. D.B. Agus D.W. Golde G. Sgouros A. Ballangrudm C. Cordon-Cardo I.H. Sher Positron emission tomography of a human prostate cancer xenograft association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal Cancer Res. 58 1998 3009 3014
20. M. Imbriaco S.M. Larson A new parameter for measuring metastatic bone involvement by prostate cancer the bone scan index Clin. Can. Res. 4 1998 1765 1772
21. Y.E. Erdi J.L. Humm M. Imbriaco H. Yeung S.M. Larson Quantitative bone metastases analysis based on image segmentation J. Nucl. Med. 38 1997 1401 1406